TerrAscend (TSNDF) Return on Capital Employed (2022 - 2026)
TerrAscend (TSNDF) reported Return on Capital Employed of 8.51% for Q1 2026, up 779.0% year-over-year from 0.97% in Q1 2025, and down 3.57% quarter-over-quarter from 8.82% in Q4 2025.
TerrAscend (TSNDF) Return on Capital Employed (2022 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 5 years of Return on Capital Employed data on file, last reported at 8.51% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 8.51%, up 779.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 8.51% (up 779.0% YoY), and the FY2025 annual result was 8.36%, up 820.0% from the prior year.
- Return on Capital Employed fell to 8.51% in Q1 2026 per TSNDF's latest filing, from 8.82% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 53.2% in Q3 2023 and troughed at 49.12% in Q3 2022.
- A 5-year average of 0.13% and a median of 0.3% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed surged 10232 bps in 2023, then tumbled 5354 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 11.32% in 2022, then surged by 98 bps to 0.18% in 2023, then tumbled by 146 bps to 0.44% in 2024, then surged by 2089 bps to 8.82% in 2025, then slipped by 4 bps to 8.51% in 2026.
- Business Quant data shows TSNDF's Return on Capital Employed at 8.51% in Q1 2026, 8.82% in Q4 2025, and 1.64% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | TerrAscend | - | - | 34.60 Mn | 8.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.51% |
| Dec 31, 2025 | 8.82% |
| Sep 30, 2025 | 1.64% |
| Jun 30, 2025 | 0.83% |
| Mar 31, 2025 | 0.72% |
| Dec 31, 2024 | -0.44% |
| Sep 30, 2024 | -0.34% |
| Jun 30, 2024 | 1.47% |
| Mar 31, 2024 | 0.30% |
| Dec 31, 2023 | -0.18% |
| Sep 30, 2023 | 53.20% |
| Jun 30, 2023 | -6.63% |
| Mar 31, 2023 | -9.78% |
| Dec 31, 2022 | -11.32% |
| Sep 30, 2022 | -49.12% |
| Jun 30, 2022 | -1.46% |
| Mar 31, 2022 | 1.65% |